Search clinical trials for: ALK-positive NSCLC
Total 3586 results
-
Sichuan Cancer Hospital and Research InstituteRecruitingALK-positive Non-small Cell Lung Cancer | Real World StudyChina
-
Guangdong Association of Clinical TrialsNot yet recruitingCarcinoma, Non-Small-Cell Lung | Brain Metastases | Leptomeningeal MetastasisChina
-
Guangdong Association of Clinical TrialsRecruitingALK Positive Non-small Cell Lung CancerChina
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Gruppo Oncologico Italiano di Ricerca ClinicaRecruiting
-
Shanghai Fosun Pharmaceutical Industrial Development...RecruitingAdvanced Solid Tumor | Advanced Cancer | Lung Cancer, Nonsmall CellChina
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Sichuan Cancer Hospital and Research InstituteActive, not recruitingBrain Metastases | ALK-positive Non-small Cell Lung Cancer | Meningeal MetastasisChina
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
TakedaCompletedALK-positive Advanced NSCLCJapan
-
Hoffmann-La RocheActive, not recruitingNSCLCBelgium, Australia, China, Croatia, Finland, Turkey, Italy, Israel, Serbia, Austria, Romania, Peru, Lithuania, Colombia, Portugal, Czechia, Cuba, Russian Federation, Bulgaria, Vietnam, Uruguay, United Arab Emirates, Argentina, Chile, Pa...
-
PfizerCompletedALK-positive Non-small-cell Lung CancerJapan
-
Intergroupe Francophone de Cancerologie ThoraciqueActive, not recruitingNon Small Cell Lung Cancer MetastaticFrance
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States, Spain, United Kingdom, Japan, Turkey, Belgium, Germany, Netherlands, Canada, Singapore, Switzerland, Israel, Russian Federation, Korea, Republic of, Hong Kong, Lebanon, Italy, France, Portugal, Ireland
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Ludwig Institute for Cancer ResearchXcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...CompletedCarcinoma | NSCLC | Non-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.TerminatedALK-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Non-small Cell Lung Cancer (NSCLC) | RET-positive Thyroid CancerUnited States
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
PfizerMerck Sharp & Dohme LLCTerminatedALK-positive Advanced NSCLCUnited States
-
Novartis PharmaceuticalsCompleted
-
Jewish General HospitalPfizer; PeriPharm; Quebec Clinical Research Organization in Cancer; Personalized...UnknownNon-small Cell Lung Cancer MetastaticCanada
-
Henan Cancer HospitalRecruitingNon-Small Cell Lung CancerChina
-
Karl Landsteiner Institute for Lung Research and...Klinik Pirawarth; Therme Wien MedNot yet recruiting
-
Shanghai Chest HospitalNot yet recruitingStage II-III Non-small Cell Lung Cancer
-
Sir Run Run Shaw HospitalNot yet recruitingNon-Small-Cell Lung Cancer
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced Non-small Cell Lung Cancer
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | EGFR Gene Mutation | Non-small Cell Lung Cancer Stage IV
-
AmgenNot yet recruitingEarly-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Leptomeningeal Metastasis | Low Dose RadiotherapyChina
-
Beijing Geekgene Technology Co., LTDRecruitingCervical Cancer | Gastric Cancer | Esophageal Cancer | Non-Small Cell Lung Cancer NSCLC | Triple Negative Breast Cancer TNBCChina
-
BeiGeneNot yet recruitingMetastatic Solid Tumor | Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Alpha-fetoprotein (AFP)-Producing Gastric Cancer | Extragonadal Yolk Sac Tumors | Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
-
Sun Yat-sen UniversityNot yet recruitingLung Cancer, Nonsmall Cell
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Zeng JianRecruiting
-
Beijing Cancer Prevention & Treatment SocietyCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruiting
-
Merck Sharp & Dohme LLCNot yet recruiting
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
National Cancer Center, ChinaNot yet recruiting
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruiting
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruitingFirst-line Advanced NSCLC PatientsChina
-
Henan University of Traditional Chinese MedicineRecruiting
-
Guangdong Provincial People's HospitalRecruitingNSCLC, Stage I | Disease Free Survival | Pulmonary Function AssessmentChina
-
GlaxoSmithKlineNot yet recruiting